Enabling a Healthier World
De-risk Early
Stage Drug
Development
With Lonza
Small Molecules
Our team of experts have a wide
range of skills to support you with
your early phase challenges.
Solid Form Screening Services
Physiologically Based
Pharmacokinetic Modeling Services
AI-Enabled Route Scouting Services
We will help you determine the most suitable chemical and
physical form for your API. Our SFS services are built on a
foundation of API characterization, materials science, and
problem statement analyses.
Using established ADMET Predictor and GastroPlus modeling
software, linked with an expansive set of in vitro tests, we can
identify absorption risks, and select technologies that will enable
bioperformance targets to be met.
® ®
Our experts use a range of retrosynthetic technologies,
powered by in-house AI expertise, real-world chemical and
commercial data, to help you implement shorter, more
efficient synthetic routes for making your NMEs.
Scan the QR code to learn
more about our services
and experts who can
support you with your
early-phase challenges
NEW
